OrbiMed Israel BioFund GP Limited Partnership - Significant Ownership

Signature - Title
/s/ Carl L. Gordon - Carl L. Gordon/Director
Location
Herzliya, Israel
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by OrbiMed Israel BioFund GP Limited Partnership.

Significant Ownership of OrbiMed Israel BioFund GP Limited Partnership

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CMMB Chemomab Therapeutics Ltd. Ordinary Shares, no par value. American Depository Shares, each of which represents twenty Ordinary Shares, no par value 4.8% $1.18M 970K ORBIMED ISRAEL BIOFUND GP LIMITED PARTNERSHIP Jun 18, 2025
PHGE BiomX Inc. Common stock, par value $0.0001 per share 1% 276K ORBIMED ISRAEL GP LTD. Jun 18, 2025

Schedules 13D/G Reported by OrbiMed Israel BioFund GP Limited Partnership:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.